Valuation (53%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -2.86 | N/A |
PEG Ratio (TTM) | 0.11 | N/A |
P/S Ratio (TTM) | 0.67 | N/A |
P/B Ratio (TTM) | 0.62 | N/A |
P/FCF Ratio (TTM) | 102.22 | N/A |
Price to 5YR AVG Earnings Ratio | -2.19 | N/A |
Price to 5YR AVG FCF Ratio | 2.16 | N/A |
Profitability (0%) |
Company | Industry |
---|---|---|
ROA (TTM) | -0.49% | N/A |
ROE (TTM) | -25.53% | N/A |
Net Profit Margin (TTM) | -28.20% | N/A |
ROIC 5YR AVG | -6.77% | N/A |
Growth (25%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | 346.86% | -56.45% | -2,763.02% |
Revenue | 435.71% | -4.39% | -9.19% |
Net Income | 69.84% | -46.13% | -2,249.74% |
Cash Flow | -108.41% | -35.91% | -54.78% |
Health (33%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | N/A | N/A |
Quick Ratio (TTM) | N/A | N/A |
D/E Ratio (TTM) | 0.57 | N/A |
Interest Coverage (TTM) | -2.48 | N/A |
Piotroski F-Score | 2 | N/A |
Altman Z-Score | 0.53 | N/A |
LTL to 5YR AVG FCF | 7.26 | N/A |
Shares Outstanding Growth 5YR AVG | -11.51% | N/A |